130 related articles for article (PubMed ID: 17634441)
21. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
[TBL] [Abstract][Full Text] [Related]
22. Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis.
Sievers P; Uhlmann L; Korkmaz-Icöz S; Fastner C; Bea F; Blessing E; Katus HA; Preusch MR
Drug Des Devel Ther; 2015; 9():3935-42. PubMed ID: 26251572
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological inhibition of cathepsin S decreases atherosclerotic lesions in Apoe-/- mice.
Samokhin AO; Lythgo PA; Gauthier JY; Percival MD; Brömme D
J Cardiovasc Pharmacol; 2010 Jul; 56(1):98-105. PubMed ID: 20410833
[TBL] [Abstract][Full Text] [Related]
24. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits.
Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Mar; 31(3):575-84. PubMed ID: 18497479
[TBL] [Abstract][Full Text] [Related]
25. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.
de Nooijer R; Verkleij CJ; von der Thüsen JH; Jukema JW; van der Wall EE; van Berkel TJ; Baker AH; Biessen EA
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):340-6. PubMed ID: 16306430
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice.
Koga M; Kai H; Yasukawa H; Yamamoto T; Kawai Y; Kato S; Kusaba K; Kai M; Egashira K; Kataoka Y; Imaizumi T
Circ Res; 2007 Aug; 101(4):348-56. PubMed ID: 17495225
[TBL] [Abstract][Full Text] [Related]
28. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
29. Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice.
van der Hoorn JW; Kleemann R; Havekes LM; Kooistra T; Princen HM; Jukema JW
J Hypertens; 2007 Dec; 25(12):2454-62. PubMed ID: 17984667
[TBL] [Abstract][Full Text] [Related]
30. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
[TBL] [Abstract][Full Text] [Related]
31. Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice.
Zhang LN; Velichko S; Vincelette J; Fitch RM; Vergona R; Sullivan ME; Croze E; Wang YX
Atherosclerosis; 2008 Mar; 197(1):204-11. PubMed ID: 17466308
[TBL] [Abstract][Full Text] [Related]
32. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
33. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.
Saraff K; Babamusta F; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1621-6. PubMed ID: 12855482
[TBL] [Abstract][Full Text] [Related]
34. Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models.
Tomono Y; Iwai M; Inaba S; Mogi M; Horiuchi M
Am J Hypertens; 2008 Feb; 21(2):206-12. PubMed ID: 18188158
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.
Yamamoto S; Zhong J; Yancey PG; Zuo Y; Linton MF; Fazio S; Yang H; Narita I; Kon V
Atherosclerosis; 2015 Sep; 242(1):56-64. PubMed ID: 26184694
[TBL] [Abstract][Full Text] [Related]
36. Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis.
Nagy N; Melchior-Becker A; Fischer JW
Basic Res Cardiol; 2010 Jan; 105(1):29-38. PubMed ID: 19701787
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
Manning MW; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):483-8. PubMed ID: 12615694
[TBL] [Abstract][Full Text] [Related]
38. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
40. ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice.
Zhou Y; Wang S; Qiu Z; Song X; Pan Y; Hu X; Zhang H; Deng Y; Ding D; Wu H; Yang S; Wang M; Zhou Z; Liao Y; Chen X
J Hypertens; 2016 Mar; 34(3):474-85; discussion 485. PubMed ID: 26771341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
